CHRONIC OBSTRUCTIVE PULMONARY DISEASE AS A FACTOR FOR THE DEVELOPMENT OF RENAL DYSFUNCTION

DOI: https://doi.org/10.29296/25877305-2018-03-05
Download full text PDF
Issue: 
3
Year: 
2018

Professor E. Bolotova(1), MD; V. Yavlyanskaya(1, 2); A. Dudnikova(2), Candidate of Medical Sciences 1-Kuban State University, Ministry of Health of Russia, Krasnodar 2-Territorial Clinical Hospital Two, Krasnodar

The paper presents the factors and mechanisms of renal dysfunction in patients with chronic obstructive pulmonary disease. Special attention is paid to the role of systemic inflammation.
Keywords: 
pulmonology
nephrology
chronic kidney disease
systemic effects of chronic obstructive pulmonary disease
comorbidity
risk factors

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Smirnov A.V., Dobronravov V.A., Kajukov I.G. i dr. Hronicheskaja bolezn' pochek: osnovnye printsipy skrininga, diagnostiki, profilaktiki i podhody k lecheniju. Natsional'nye rekomendatsii // Nefrologija. – 2012; 1: 89–115.
  2. Temgoua M., Danwang C., Agbor V. et al. Prevalence, incidence and associated mortality of cardiovascular disease in patients with chronic kidney disease in low- and middle-income countries: a protocol for a systematic review and meta-analysis // BMJ Open. – 2017; 7 (8): e016412. DOI: 10.1136/bmjopen-2017-016412.
  3. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 // Lancet. – 2016; 388 (10053): 1659–724. DOI: 10.1016 / S0140-6736 (16) 31679-8.
  4. Bikbov B.T., Tomilina N.A. Rannee vyjavlenie hronicheskoj bolezni pochek: marker preemstvennosti v lechenii patsientov, vlijanie na vyzhivaemost' i kardiovaskuljarnuju letal'nost' bol'nyh na dialize // Ros. med. zhurn. – 2014; 1: 12–7.
  5. Van J., Scholey J., Konvalinka A. Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics // J. Am. Soc. Nephrol. – 2017; 28 (4): 1050–61. DOI: 10.1681/ASN.2016091018.
  6. Helal I., Fick-Brosnahan G., Reed-Gitomer B. et al. Glomerular hyperfiltration: definitions, mechanisms and clinical implications // Nat. Rev. Nephrol. – 2012; 8 (5): 293–300. DOI: 10.1038/nrneph.2012.19.
  7. Gaddam S., Gunukula S., Lohr J. et al. Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis // BMC Pulmon. Med. – 2016; 16: 158. DOI: 10.1186/s12890-016-0315-0.
  8. Report GOLD: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org. January 2015.
  9. Schnell K., Weiss C., Lee T. et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999– 2008 // BMC Pulmon. Med. – 2012; 12: 26.
  10. Van Gestel Y., Chonchol M., Hoeks S. et al. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients // Nephrol. Dial. Transplant. – 2009; 24 (9): 2763–7. DOI: 10.1093/ndt/gfp171.
  11. Chen C.-Y., Liao K.-M. Chronic Obstructive Pulmonary Disease is associated with risk of Chronic Kidney Disease: A Nationwide Case-Cohort Study // Scientific Reports. – 2016; 6: 25855.
  12. Chandra D., Stamm J., Palevsky P. et al. The relationship between pulmonary emphysema and kidney function in smokers // Chest. – 2012; 142 (3): 655–62.
  13. Fedeli U., De Giorgi A., Gennaro N. et al. Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy // Int. J. Chronic Obstruct. Pulmon. Dis. – 2017; 12: 443–50. DOI: 10.2147/COPD.S119390.
  14. Fabbian F., De Giorgi A., Manfredini F. et al. Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study // Intern. Emerg. Med. – 2016; 11: 825. DOI: 10.1007/s11739-016-1438-2.
  15. Ibrahim I., Elmahallawy A., Qora A. Mahmoud. Prevalence of chronic renal failure in COPD patients // Egyptian J. Chest Dis. Tubercul. – 2013; 62: 221–7.
  16. Luttropp K., Debowska M., Lukaszuk T. et al. Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease // Nephrol. Dial. Transplant. – 2016; 31 (12): 2033–40.
  17. Zager R., Johnson A., Becker K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and «end-stage» kidney disease // Am. J. Physiol. Renal. Physiol. – 2011; 301 (6): 1334–45. DOI: 10.1152/ajprenal.00431.2011.
  18. Barakat M., McDonald H., Collier T. et al. Acute kidney injury in stable COPD and at exacerbation // Int. J. Chronic Obstruct. Pulmon. Dis. – 2015; 10: 2067–77. DOI: 10.2147/COPD.S88759.
  19. Bolotova E.V., Dudnikova A.V. Hronicheskaja bolezn' pochek u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih: rol' chastoty obostrenij // Pul'monologija. – 2016; 26 (4): 578–84. DOI: 10.18093/0869-0189-2016-26-5-578-583.
  20. Bolotova E.V., Dudnikova A.V. Cravnitel'naja informativnost' metodov diagnostiki proteinurii u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih // Klin. nefrologija. – 2016; 2: 33–7.